12 results
·
29ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
VITROS Immunodiagnostic Products Syphilis Reagent Pack
FDA 510(k)
FDA Class 2
·Microbiology
Millennium
FDA UDI
Avalign Technologies, Inc.·00190776191030·Tapered Retractor Blade
ELMED
FDA UDI
ELMED INCORPORATED·00842180156319·TAPERED MALLEABLE BLACK BLADE 1/16" X 1/4" WIDE...
BD VENFLON¿ PRO SAFETY SHIELDED IV CATHETER
FDA Adverse Event
Malfunction
·BECTON DICKINSON MEDICAL (SINGAPORE)·Product code FOZ·March 16, 2020
RevoLix HTL
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
SENSITITRE HAEMOPHILUS/STREPTOCOCCUS PNEUMONIAE (HP) MIC SUSCEPTIBILITY PLATE AND SUSCEPTIBILITY TEST PANEL
FDA 510(k)
FDA Class 2
·Microbiology
M.U.S.T. PEDICLE SCREW SYSTEM
FDA Adverse Event
Injury
·MEDACTA INTERNATIONAL SA·Product code PML·February 26, 2026
ALARIS INFUSION SYSTEM
FDA Adverse Event
Injury
·CARDINAL HEALTH ALARIS PRODUCTS·Product code FRN·November 21, 2008
U BY KOTEX CLICK TAMPONS
FDA Adverse Event
Malfunction
·QINGDAO P&B CO, LTD·Product code HEB·August 29, 2011
LINEAGE(R) PC QUAD HEMI FLR STD SHELL
FDA Adverse Event
Injury
·WRIGHT MEDICAL TECHNOLOGY, INC.·Product code LPH·July 22, 2013
M.U.S.T. PEDICLE SCREW SYSTEM
FDA Adverse Event
Malfunction
·MEDACTA INTERNATIONAL SA·Product code PML·November 13, 2025
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014